Investing Profile

Kanad Das

InvestorVC
Investment Director at Boehringer Ingelheim Venture Fund
boehringer-ingelheim-venture....San Francisco, California
Photo of Kanad Das, Investor at Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$3.3M - $17.0M
$8.5M
4
CompanyStageDateRound SizeTotal Raised
Actym Therapeutics, Inc.
Series AOct 2023$26M
Series AApr 2020$34M
$60M
Co-investors: Alexis Yongmei Ji (Illumina Ventures)
Viron
Series BDec 2021$50M
Series AJun 2019$25M
$75M
Co-investors: Widya Mulyasasmita (B Capital Group)